1.Alteration of White Matter Integrity in Dyslexic Children: Case-Control Study
Sung Yeol PARK ; Jae Hyun YOO ; Minhwa YANG ; Bobae KIM ; Bung Nyun KIM
Journal of Korean Neuropsychiatric Association 2019;58(2):146-150
		                        		
		                        			
		                        			OBJECTIVES: To compare the white matter microstructure of dyslexic children with normal children using diffusion tensor imaging. METHODS: Twenty one dyslexic children and 24 normal control children were recruited in the second and third grade of elementary school students. The fractional anisotropy (FA) values of 20 representative white matter tracts were estimated from the diffusion tensor imaging data of each subject using the Johns Hopkins University-white matter tractography atlas to determine the difference in white matter integrity between the dyslexic children and normal children. RESULTS: Compared to the normal control group, the FA values of the left inferior longitudinal fasciculus [F(1,39)=5.908, p<0.05] and temporal part of the right superior longitudinal fasciculus [F(1,39)=7.328, p=0.010] were significantly higher in the dyslexic group and there was no significant difference in the other tracts. CONCLUSION: In dyslexic children, compensatory pathways develop in the left inferior longitudinal fasciculus and in the temporal part of the right superior longitudinal fasciculus.
		                        		
		                        		
		                        		
		                        			Anisotropy
		                        			;
		                        		
		                        			Case-Control Studies
		                        			;
		                        		
		                        			Child
		                        			;
		                        		
		                        			Diffusion Tensor Imaging
		                        			;
		                        		
		                        			Dyslexia
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			White Matter
		                        			
		                        		
		                        	
2.CCCTC-binding factor is essential to the maintenance and quiescence of hematopoietic stem cells in mice.
Tae Gyun KIM ; Sueun KIM ; Soyeon JUNG ; Mikyoung KIM ; Bobae YANG ; Min Geol LEE ; Hyoung Pyo KIM
Experimental & Molecular Medicine 2017;49(8):e371-
		                        		
		                        			
		                        			Hematopoiesis involves a series of lineage differentiation programs initiated in hematopoietic stem cells (HSCs) found in bone marrow (BM). To ensure lifelong hematopoiesis, various molecular mechanisms are needed to maintain the HSC pool. CCCTC-binding factor (CTCF) is a DNA-binding, zinc-finger protein that regulates the expression of its target gene by organizing higher order chromatin structures. Currently, the role of CTCF in controlling HSC homeostasis is unknown. Using a tamoxifen-inducible CTCF conditional knockout mouse system, we aimed to determine whether CTCF regulates the homeostatic maintenance of HSCs. In adult mice, acute systemic CTCF ablation led to severe BM failure and the rapid shrinkage of multiple c-Kit(hi) progenitor populations, including Sca-1⁺ HSCs. Similarly, hematopoietic system-confined CTCF depletion caused an acute loss of HSCs and highly increased mortality. Mixed BM chimeras reconstituted with supporting BM demonstrated that CTCF deficiency-mediated HSC depletion has both cell-extrinsic and cell-intrinsic effects. Although c-Kit(hi) myeloid progenitor cell populations were severely reduced after ablating Ctcf, c-Kit(int) common lymphoid progenitors and their progenies were less affected by the lack of CTCF. Whole-transcriptome microarray and cell cycle analyses indicated that CTCF deficiency results in the enhanced expression of the cell cycle-promoting program, and that CTCF-depleted HSCs express higher levels of reactive oxygen species (ROS). Importantly, in vivo treatment with an antioxidant partially rescued c-Kit(hi) cell populations and their quiescence. Altogether, our results suggest that CTCF is indispensable for maintaining adult HSC pools, likely by regulating ROS-dependent HSC quiescence.
		                        		
		                        		
		                        		
		                        			Adult
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Bone Marrow
		                        			;
		                        		
		                        			Cell Cycle
		                        			;
		                        		
		                        			Chimera
		                        			;
		                        		
		                        			Chromatin
		                        			;
		                        		
		                        			Fibrinogen*
		                        			;
		                        		
		                        			Hematopoiesis
		                        			;
		                        		
		                        			Hematopoietic Stem Cells*
		                        			;
		                        		
		                        			Homeostasis
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lymphoid Progenitor Cells
		                        			;
		                        		
		                        			Mice*
		                        			;
		                        		
		                        			Mice, Knockout
		                        			;
		                        		
		                        			Mortality
		                        			;
		                        		
		                        			Myeloid Progenitor Cells
		                        			;
		                        		
		                        			Reactive Oxygen Species
		                        			
		                        		
		                        	
3.Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.
Yoon Yang JUNG ; Chang Lim HYUN ; Min Sun JIN ; In Ae PARK ; Yul Ri CHUNG ; Bobae SHIM ; Kyu Ho LEE ; Han Suk RYU
Journal of Breast Cancer 2016;19(3):261-267
		                        		
		                        			
		                        			PURPOSE: There is no standard targeted therapy for the treatment of triple-negative breast cancer (TNBC). Therefore, its management heavily depends on adjuvant chemotherapy. Using core needle biopsy, this study evaluated the histological factors of TNBC predicting the response to chemotherapy. METHODS: One hundred forty-three TNBC patients who received single-regimen neoadjuvant chemotherapy (NAC) with the combination of doxorubicin, cyclophosphamide, and docetaxel were enrolled. The core needle biopsy specimens acquired before NAC were used to analyze the clinicopathologic variables and overall performance of the predictive model for therapeutic response. RESULTS: Independent predictors of pathologic complete response after NAC were found to be higher number of tumor infiltrating lymphocytes (p=0.007), absence of clear cytoplasm (p=0.008), low necrosis (p=0.018), and high histologic grade (p=0.039). In the receiver operating characteristics curve analysis, the area under curve for the combination of these four variables was 0.777. CONCLUSION: The present study demonstrated that a predictive model using the above four variables can predict therapeutic response to single-regimen NAC with the combination of doxorubicin, cyclophosphamide, and docetaxel in TNBC. Therefore, adding these morphologic variables to clinical and genomic signatures might enhance the ability to predict the therapeutic response to NAC in TNBC.
		                        		
		                        		
		                        		
		                        			Area Under Curve
		                        			;
		                        		
		                        			Biopsy, Large-Core Needle
		                        			;
		                        		
		                        			Chemotherapy, Adjuvant
		                        			;
		                        		
		                        			Cyclophosphamide
		                        			;
		                        		
		                        			Cytoplasm
		                        			;
		                        		
		                        			Doxorubicin
		                        			;
		                        		
		                        			Drug Therapy*
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lymphocytes, Tumor-Infiltrating
		                        			;
		                        		
		                        			Necrosis
		                        			;
		                        		
		                        			Neoadjuvant Therapy
		                        			;
		                        		
		                        			ROC Curve
		                        			;
		                        		
		                        			Treatment Outcome
		                        			;
		                        		
		                        			Triple Negative Breast Neoplasms*
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail